Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients.

@article{Nishikawa2016ClinicalIO,
  title={Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients.},
  author={Hiroki Nishikawa and Hirayuki Enomoto and Yoshinori Iwata and Kyohei Kishino and Yoshihiro Shimono and Kunihiro Hasegawa and C. Greene Nakano and Ryo Takata and Takashi Nishimura and Kazunori Yoh and Akiio Ishii and Nobuhiro Aizawa and Yoshiyuki Sakai and Naoto Ikeda and Tomoyuki Takashima and Hiroko Iijima and Shuhei Nishiguchi},
  journal={Hepatology research : the official journal of the Japan Society of Hepatology},
  year={2016},
  volume={46 11},
  pages={1065-1073}
}
AIM To examine the impact of pretreatment Wisteria floribunda agglutinin positive Mac-2-binding protein (WFA+ -M2BP) level on hepatitis B e-antigen (HBeAg) loss or HBeAg seroconversion (SC) for patients with nucleoside/nucleotide analog (NUC) therapy naive HBeAg positive chronic hepatitis B (CHB). METHODS A total of 57 patients were analyzed. All subjects were initially treated with NUC. We examined the impact of pretreatment WFA+ -M2BP level on HBeAg loss and HBeAg SC using univariate and… CONTINUE READING
2 Citations
37 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis

  • AS Lok, BJ McMahon, RS JrBrown
  • Hepatology
  • 2016

Serum WFA +  M 2 BP is a non - invasive liver fi brosis marker that can predict the ef fi cacy of direct - acting anti - viral - based triple therapy for chronic hepatitis C

  • K Ura, N Furusyo, E Ogawa
  • Aliment Pharmacol Ther
  • 2016

Similar Papers

Loading similar papers…